A major breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This vital malignant inhibitor protein is frequently inactivated in several kinds of cancer, resulting https://olivebookmarks.com/story22031018/mini-antibodies-revive-the-p53-protein-new-potential-pathway-for-malignant-treatment